Kona-based Cyanotech Corp. said Thursday that record sales of microalgae products helped boost its net income 22 percent in the quarter ended June 30 compared with the same three-month period a year earlier.

The company’s shares jumped 8 percent to close at $3.95 on the news.

Cyanotech reported net income of $486,000, or 9 cents a share in the latest quarter, up from $399,000, or 7 cents a share, for the same quarter a year earlier.

The earnings came on record sales of $5.95 million in the April-to-June quarter compared with sales of $2.09 million a year earlier.

Cyanotech makes high-value nutrition and health products from microalgae. Sales of both of Cyanotech’s core products, Spirulina Pacifica and BioAstin Natural Astaxanthin, grew during the quarter, the company reported.

"The significant increases in packaged product sales are attributed to our focus on the growing consumer market for health and nutrition supplement products, combined with recent media reports regarding the benefits of both astaxanthin and spirulina," said Brent Bailey, Cyanotech president and chief executive officer.

"We believe that Cyanotech’s high-quality, Hawaiian spirulina and natural astaxanthin will continue to benefit from increasing general consumer demand for natural nutritional products with proven value."

The company reported it had $3.1 million in cash and cash equivalents as of June 30, compared with $2.1 million as of March 31. Working capital increased to $6.7 million from $6.3 million during the same period.

All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona using patented and proprietary technology.

Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 50 countries worldwide.